Federal Circuit Gives Teva Go-Ahead For Generic Biaxin

Law360, New York (June 22, 2006, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit Thursday threw out a preliminary injunction barring Israeli drug maker Teva Pharmaceutical Industries Ltd. from selling a generic version of Abbott Laboratories’ extended-release antibiotic Biaxin.

Teva had appealed to the circuit court after a judge with the U.S. District Court for the Northern District of Illinois in Chicago granted Abbott’s request for a temporary injunction in June 2005.

On Thursday, the U.S. Court of Appeals for the Federal Circuit disagreed with the lower court, stating that Teva...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.